KAREN WATSON

Allopathic & Osteopathic Physicians|Internal Medicine GREENVILLE, SC NPI 1760423909

General Payments — all program years on this page

$3,272.57

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 214
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $416.61 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $416.6121

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $513.4439
2019 $810.7861
2020 $405.3221
2021 $614.3541
2022 $384.0925
2023 $127.986
2024 $416.6121

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086109124 Bayer Healthcare Pharmaceuticals Inc. $14.63 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096814368 Novo Nordisk Inc $16.22 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096899122 Novo Nordisk Inc $17.84 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096948994 Novo Nordisk Inc $16.17 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104275561 AstraZeneca Pharmaceuticals LP $18.24 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104675489 AstraZeneca Pharmaceuticals LP $17.13 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105745873 AstraZeneca Pharmaceuticals LP $24.53 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106313209 ABBVIE INC. $31.29 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110757340 Eisai Inc. $34.37 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114946056 Exact Sciences Corporation $18.02 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116629744 GlaxoSmithKline, LLC. $19.94 08/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125250442 Abbott Laboratories $18.85 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125250446 Abbott Laboratories $23.65 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132088447 PFIZER INC. $18.92 10/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135076235 Lilly USA, LLC $18.29 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135117901 Lilly USA, LLC $17.02 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135120121 Lilly USA, LLC $18.06 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140173764 Inari Medical, Inc. $22.86 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151137951 Phathom Pharmaceuticals, Inc. $13.37 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153312925 Dexcom, Inc. $17.60 07/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153453001 Salix Pharmaceuticals, a division of Bausch Health US, LLC $19.61 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.